|
WO2021053018A1
|
|
Targeting misspliced transcripts in genetic disorders
|
|
WO2020104469A1
|
|
Method and means to deliver mirna to target cells
|
|
WO2020104435A1
|
|
A companion diagnostic to monitor the effects of gene therapy
|
|
WO2020104424A1
|
|
Liver-specific viral promoters and methods of using the same
|
|
WO2020104295A1
|
|
Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
|
|
WO2020053258A1
|
|
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
|
CA3084452A1
|
|
Modified viral vectors and methods of making and using the same
|
|
EP3727466A1
|
|
Methods of improving adeno-associated viral transduction
|
|
WO2019016349A1
|
|
Improved aav capsid production in insect cells
|
|
EP3652326A1
|
|
Means and methods for aav gene therapy in humans
|
|
EP3554579A1
|
|
Immunoadsorption
|
|
AU2016202153A1
|
|
Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV in insect cells
|
|
AU2015370903A1
|
|
RNAi induced huntingtin gene suppression
|
|
CN107208142A
|
|
DNA impurity in composition comprising the viral body of parvovirus
|
|
WO2015137802A1
|
|
Further improved aav vectors produced in insect cells
|
|
AU2014337783A1
|
|
AAV-5 pseudotyped vector for gene therapy for neurological diseases
|
|
AU2014201171A1
|
|
Baculoviral vectors comprising repeated coding sequences with differential codon biases
|
|
AU2013254897A1
|
|
Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV in insect cells
|
|
EP2744895A1
|
|
Removal of contaminating viruses from aav preparations
|
|
EP3792348A2
|
|
Mutated rep encoding sequences for use in aav production
|
